Concord Healthcare Group

Concord Healthcare Group operates multiple self-owned oncology specialty hospitals and outpatient centers in China’s Greater Bay Area and Yangtze River Delta regions. The group specializes in comprehensive cancer diagnosis and treatment services including advanced radiotherapy techniques such as proton therapy (in preparation), breast-conserving surgery with high success rates (>40% in 2023), complex general surgeries, diagnostic imaging, internet hospital platforms for telemedicine access, and supply chain expansion to support other medical institutions. The company also provides medical equipment sales/leasing/services to third-party institutions.